» Articles » PMID: 37795707

Genetic Markers of Chronic Lymphocytic Leukemia: a Retrospective Study of 312 Patients from a Reference Center in Lebanon

Overview
Journal Future Oncol
Specialty Oncology
Date 2023 Oct 5
PMID 37795707
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic lymphocytic leukemia (CLL) is a highly heterogenous hemopathy. Genetic stratification of CLL patients has important prognostic and therapeutic values - mainly immunoglobulin heavy chain variable region gene () mutational status and the presence of cytogenetic abnormalities. The genetics of CLL in Lebanon is scarcely described in the literature. In this work, we studied the genetic biomarkers of 312 Lebanese CLL patients. Prominent IGHV genes were , and ; and CLL #1 and #5 presented major subsets. Some similarities as well as major differences were highlighted when comparing our data with previously published data. The distribution of alleles in our series differed from previously described distributions, suggesting involvement of antigenic selection and regional variables in CLL pathogenesis.

Citing Articles

Complex karyotypes in hematologic disorders: a 12-year single-center study from Lebanon.

Rammal S, Abou Abdallah F, Attieh C, El Mounajjed Z, Semaan W, Chebly A Front Oncol. 2024; 14:1480793.

PMID: 39512772 PMC: 11540823. DOI: 10.3389/fonc.2024.1480793.


Spotlight on borderline-IGHV mutational status in chronic lymphocytic leukemia.

Rammal S, Semaan W, Aprahamian N, Moussallem R, Chebly A Front Oncol. 2024; 14:1430225.

PMID: 38903722 PMC: 11187082. DOI: 10.3389/fonc.2024.1430225.


Chronic Lymphocytic Leukemia (CLL) with Borderline Immunoglobulin Heavy Chain Mutational Status, a Rare Subgroup of CLL with Variable Disease Course.

Angotzi F, Cellini A, Ruocco V, Cavarretta C, Zatta I, Serafin A Cancers (Basel). 2024; 16(6).

PMID: 38539430 PMC: 10969134. DOI: 10.3390/cancers16061095.


Clinical utility of keratin 14 expression measurement in reflecting the tumor properties and prognosis in patients with renal cell carcinoma: a study with long-term follow-up.

Wang S, Gao P, Wang X, Duan L, He X, Qu J Int Urol Nephrol. 2024; 56(6):2045-2053.

PMID: 38206525 DOI: 10.1007/s11255-023-03923-4.